about
Sex Differences in Serum Markers of Major Depressive Disorder in the Netherlands Study of Depression and Anxiety (NESDA).Variation in serum biomarkers with sex and female hormonal status: implications for clinical testsPerturbational Profiling of Metabolites in Patient Fibroblasts Implicates α-Aminoadipate as a Potential Biomarker for Bipolar Disorder.Endothelial damage in major depression patients is modulated by SSRI treatment, as demonstrated by circulating biomarkers and an in vitro cell model.Association study of MIF promoter polymorphisms with suicide completers in the Japanese population.Peripheral biomarkers of major depression and antidepressant treatment response: Current knowledge and future outlooks.Systems Genomics Support for Immune and Inflammation Hypothesis of Depression.Parallel changes in serum proteins and diffusion tensor imaging in methamphetamine-associated psychosis.Proteomics insight into psychiatric disorders: an update on biological fluid biomarkers.Components of the metabolic syndrome and depressive symptoms in community-dwelling older people: the Bambuí Cohort Aging Study.Serum proteomic profiles of depressive subtypesInnovative biomarkers in psychiatric disorders: a major clinical challenge in psychiatry.Associations between SNPs and immune-related circulating proteins in schizophrenia.Proteomics profiling reveals inflammatory biomarkers of antidepressant treatment response: Findings from the CO-MED trial.Enhanced Molecular Aging in Late-Life Depression: the Senescent-Associated Secretory Phenotype.Cerebrospinal Fluid Concentrations of Neuronal Proteins Are Reduced in Primary Angiitis of the Central Nervous System.Proteomics for blood biomarker exploration of severe mental illness: pitfalls of the past and potential for the future
P2860
Q36032426-DFD70C5F-A27D-4694-8737-581E3DD3C200Q36949654-05A07CE0-399B-42CC-8FB1-04C5B2145FB1Q37200180-8ADF087B-EE65-4251-A64B-EF2E2B9B92CBQ37307167-91375FB6-4EA6-40AB-9BB6-3CA307A08651Q37726134-ABF8B3C1-C510-4F86-8A8A-3C856C46472FQ38657429-8AB4EB2C-1528-4C26-A47A-8036643A9931Q38687599-B8146CAC-9285-4355-B1FC-1E2701BEA5C0Q38933936-85F89154-520A-4852-B5B5-CDF9FEFF5E22Q38939217-5DABAB91-5A42-44CD-8ECC-F2C1528AF554Q39504880-6E29F974-9ADC-4F41-BAE0-4D783AB9A8ACQ39610291-36DB375B-CB07-4C3F-B76F-35D48CC742C7Q40058836-139D5AEE-DF68-4372-BACE-3C25C8E60373Q42002123-A5C0EE37-3030-4344-9109-D9FD0FFC00B4Q47852075-2C189512-CE61-4816-AAB5-0CF3A9C801D8Q47876260-C8AA3BBF-C1D2-4068-97EE-388F63ED0D52Q55231882-975555F9-D741-4FAC-BF8F-B7E5AFF3A834Q57169146-888CB515-EBA2-4581-B334-00674BDE201C
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 July 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Serum proteomic profiling of major depressive disorder.
@en
Serum proteomic profiling of major depressive disorder.
@nl
type
label
Serum proteomic profiling of major depressive disorder.
@en
Serum proteomic profiling of major depressive disorder.
@nl
prefLabel
Serum proteomic profiling of major depressive disorder.
@en
Serum proteomic profiling of major depressive disorder.
@nl
P2093
P2860
P50
P356
P1476
Serum proteomic profiling of major depressive disorder.
@en
P2093
B W J H Penninx
F M Leweke
M Rothermundt
N Vogelzangs
P2860
P2888
P356
10.1038/TP.2015.88
P577
2015-07-14T00:00:00Z